Menu
Search
|

Menu

Close
X

Valeritas Holdings Inc VLRX.OQ (NASDAQ Stock Exchange Capital Market)

1.48 USD
-- (--)
As of Jun 20
chart
Previous Close 1.48
Open --
Volume --
3m Avg Volume 114,660
Today’s High --
Today’s Low --
52 Week High 7.20
52 Week Low 1.20
Shares Outstanding (mil) 22.39
Market Capitalization (mil) 35.16
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
3.00 Mean rating from 1 analysts

KEY STATS

Revenue (mm, USD)
FY18
6
FY17
20
FY16
20
FY15
18
EPS (USD)
FY18
-1.722
FY17
-12.609
FY16
-68.038
FY15
-95.615
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
33.88
Price to Sales (TTM)
vs sector
1.62
8.30
Price to Book (MRQ)
vs sector
--
4.32
Price to Cash Flow (TTM)
vs sector
--
22.70
Total Debt to Equity (MRQ)
vs sector
--
17.35
LT Debt to Equity (MRQ)
vs sector
--
12.89
Return on Investment (TTM)
vs sector
-115.04
13.21
Return on Equity (TTM)
vs sector
-692.35
15.18

EXECUTIVE LEADERSHIP

Peter Devlin
Chairman of the Board, Since 2017
Salary: --
Bonus: --
John Timberlake
President, Chief Executive Officer, Director, Since 2016
Salary: $389,268.00
Bonus: --
Erick Lucera
Chief Financial Officer, Executive Vice President, Since 2016
Salary: $85,000.00
Bonus: --
Geoffrey Jenkins
Executive Vice President - Manufacturing, Operations and Research & Development, Since 2009
Salary: $367,937.00
Bonus: --
Mark Conley
Vice President, Corporate Controller, Treasurer, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

750 US Highway 202 Ste 600
BRIDGEWATER   NJ   08807-2597

Phone: +1908.9279920
Site:

Valeritas Holdings, Inc. is a commercial-stage medical technology company. The Company is focused on developing technologies for Type 2 diabetes. The Company's product, the V-Go Wearable Insulin Delivery Device (V-Go), is an insulin delivery device that helps patients with Type 2 diabetes requiring insulin to maintain their target blood glucose goals. V-Go is a disposable insulin delivery device that a patient adheres to his or her skin every 24 hours. V-Go enables patients to closely mimic the body's normal physiologic pattern of insulin delivery throughout the day and to manage their diabetes with insulin without the need to plan a daily routine around multiple daily injections. The Company has developed V-Go utilizing its h-Patch platform as a patient-focused solution to address insulin therapies. Its h-Patch platform facilitates the subcutaneous delivery of injectable medicines to patients across a range of therapeutic areas.

SPONSORED STORIES